Lukes A - Search Results

Year	Number of Results
1955	1
1959	1
1976	2
1977	1
1978	1
1981	1
1984	1
1989	1
1992	1
1993	1
1994	2
1996	1
1997	2
1998	1
1999	2
2000	2
2001	3
2002	2
2004	3
2005	5
2006	1
2007	4
2008	8
2009	4
2010	4
2011	10
2012	3
2013	2
2014	4
2015	11
2016	4
2017	2
2018	4
2019	2
2020	2
2021	3
2022	3
2023	6
2024	3

1

Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long-term extension study: A descriptive subgroup analysis in women with anemia at baseline.

Venturella R, Lukes AS, Wu R, McLean R, Rakov VG, Al-Hendy A. Venturella R, et al. Among authors: lukes as. Int J Gynaecol Obstet. 2024 May;165(2):431-441. doi: 10.1002/ijgo.15505. Epub 2024 Apr 4. Int J Gynaecol Obstet. 2024. PMID: 38576220

2

A transmandibular lateral transsphenoidal navigated surgical approach to access a pituitary macroadenoma in a warmblood mare.

de Preux M, Precht C, Guevar J, Graubner C, Thenhaus-Schnabel S, Buser L, Lukes A, Koch C. de Preux M, et al. Among authors: lukes a. Vet Q. 2024 Dec;44(1):1-10. doi: 10.1080/01652176.2023.2300947. Epub 2024 Feb 23. Vet Q. 2024. PMID: 38393300 Free PMC article.

3

Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.

Stewart EA, Al-Hendy A, Lukes AS, Madueke-Laveaux OS, Zhu E, Proehl S, Schulmann T, Marsh EE. Stewart EA, et al. Among authors: lukes as. Am J Obstet Gynecol. 2024 Feb;230(2):237.e1-237.e11. doi: 10.1016/j.ajog.2023.10.030. Epub 2023 Oct 18. Am J Obstet Gynecol. 2024. PMID: 37863160 Free article. Clinical Trial.

4

LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.

Al-Hendy A, Venturella R, Arjona Ferreira JC, Li Y, Soulban G, Wagman RB, Lukes AS. Al-Hendy A, et al. Among authors: lukes as. Am J Obstet Gynecol. 2023 Dec;229(6):662.e1-662.e25. doi: 10.1016/j.ajog.2023.08.030. Epub 2023 Sep 2. Am J Obstet Gynecol. 2023. PMID: 37666383 Free article. Clinical Trial.

5

A plain language summary of the long-term relugolix combination therapy study for uterine fibroids.

Al-Hendy A, Lukes AS, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA. Al-Hendy A, et al. Among authors: lukes as. J Comp Eff Res. 2023 Aug;12(8):e230069. doi: 10.57264/cer-2023-0069. Epub 2023 Jul 21. J Comp Eff Res. 2023. PMID: 37477173 Free PMC article. Review.

6

A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women.

Lukes A, Migoya E, Johnson B, Lee TY, Li Y, Arjona Ferreira JC. Lukes A, et al. Clin Pharmacokinet. 2023 Aug;62(8):1169-1182. doi: 10.1007/s40262-023-01269-9. Epub 2023 Jun 26. Clin Pharmacokinet. 2023. PMID: 37365436 Free PMC article. Clinical Trial.

7

A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies.

Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HO, Li Y, McKain L, Arjona Ferreira JC, Langenberg AG, Wagman RB, Stewart EA. Al-Hendy A, et al. Among authors: lukes as. Pain Manag. 2023 Apr;13(4):205-211. doi: 10.2217/pmt-2022-0085. Epub 2023 May 15. Pain Manag. 2023. PMID: 37183454 Free article. Review.

8

Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.

Stewart EA, Lukes AS, Venturella R, Li Y, Hunsche E, Wagman RB, Al-Hendy A. Stewart EA, et al. Among authors: lukes as. Am J Obstet Gynecol. 2023 Mar;228(3):320.e1-320.e11. doi: 10.1016/j.ajog.2022.11.1278. Epub 2022 Nov 9. Am J Obstet Gynecol. 2023. PMID: 36370871 Free article. Clinical Trial.

9

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.

Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA. Al-Hendy A, et al. Among authors: lukes as. Obstet Gynecol. 2022 Dec 1;140(6):920-930. doi: 10.1097/AOG.0000000000004988. Epub 2022 Nov 2. Obstet Gynecol. 2022. PMID: 36357960 Free PMC article. Clinical Trial.

10

Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials.

Stewart EA, Lukes AS, Venturella R, Arjona Ferreira JC, Li Y, Hunsche E, Wagman RB, Al-Hendy A. Stewart EA, et al. Among authors: lukes as. Obstet Gynecol. 2022 Jun 1;139(6):1070-1081. doi: 10.1097/AOG.0000000000004787. Epub 2022 May 2. Obstet Gynecol. 2022. PMID: 35675604 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

103 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year